Literature DB >> 26332825

Correction: Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175.

Chetan E Chitnis, Paushali Mukherjee, Shantanu Mehta, Syed Shams Yazdani, Shikha Dhawan, Ahmad Rushdi Shakri, Rukmini Bhardwaj, Puneet Kumar Gupta, Dhiraj Hans, Suman Mazumdar, Bijender Singh, Sanjeev Kumar, Gaurav Pandey, Varsha Parulekar, Nathalie Imbault, Preethi Shivyogi, Girish Godbole, Krishna Mohan, Odile Leroy, Kavita Singh, Virander S Chauhan.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0117820.].

Entities:  

Year:  2015        PMID： 26332825      PMCID： PMC4558041          DOI： 10.1371/journal.pone.0137816

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


The seventh author’s name is spelled incorrectly. The correct name is: Rukmini Bhardwaj.
  1 in total

1.  Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175.

Authors:  Chetan E Chitnis; Paushali Mukherjee; Shantanu Mehta; Syed Shams Yazdani; Shikha Dhawan; Ahmad Rushdi Shakri; Rukmini Bhardwaj; Rukmini Bharadwaj; Puneet Kumar Gupta; Dhiraj Hans; Suman Mazumdar; Bijender Singh; Sanjeev Kumar; Gaurav Pandey; Varsha Parulekar; Nathalie Imbault; Preethi Shivyogi; Girish Godbole; Krishna Mohan; Odile Leroy; Kavita Singh; Virander S Chauhan
Journal:  PLoS One       Date:  2015-04-30       Impact factor: 3.240
  1 in total
  1 in total

Review 1.  Prospects for Malaria Vaccines: Pre-Erythrocytic Stages, Blood Stages, and Transmission-Blocking Stages.

Authors:  Jingtong Zheng; He Pan; Yinuo Gu; Xu Zuo; Nan Ran; Yuze Yuan; Chao Zhang; Fang Wang
Journal:  Biomed Res Int       Date:  2019-10-03       Impact factor: 3.411
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.